Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2024 · View financials
Decision snapshot: BHF stock price vs ZNTL: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ZNTL's multiple
Needs ZNTL P/E.
Implied fair value · at BHF's multiple
Needs EPS (TTM) is negative, BHF P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: BHF FY 2025 (ended Dec 31, 2025) · ZNTL FY 2024 (ended Dec 31, 2024). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Brighthouse Financial, Inc. · implied price per share
Bear
$89.43
Base
$105.21
Bull
$120.99
Zentalis Pharmaceuticals, Inc. · implied price per share
Bear
-$2.26
Base
-$2.66
Bull
-$3.06
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.47x
0.29x
Net debt / EBITDA
Leverage against operating earnings
-5.03x
-0.19x
Cash and equivalents
Liquid reserves on the balance sheet
$6.34B
$36.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LINCOLN NATIONAL CORP
BHF vs LNC
Jackson Financial Inc.
BHF vs JXN
METLIFE INC
BHF vs MET
PRINCIPAL FINANCIAL GROUP INC
BHF vs PFG
PRUDENTIAL FINANCIAL INC
BHF vs PRU
Arcus Biosciences, Inc.
BHF vs RCUS
Repare Therapeutics Inc.
BHF vs RPTX
IDEAYA Biosciences, Inc.
BHF vs IDYA
Mersana Therapeutics, Inc.
BHF vs MRSN
EXELIXIS, INC.
BHF vs EXEL
$3.16B
$61.78M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote
